Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Multicenter Study Evaluating the Safety of OMS103HP and Vehicle in Subjects Undergoing Anterior Cruciate Ligament Reconstruction With an Open-Label Phase Containing a PK Analysis in a Subset of Subjects

NCT00245271 is registered in ClinicalTrials.gov with Omeros Corporation as lead sponsor.

NCT NCT00245271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00245271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Multicenter Study Evaluating the Safety of OMS103HP and Vehicle in Subjects Undergoing Anterior Cruciate Ligament Reconstruction With an Open-Label Phase Containing a PK Analysis in a Subset of Subjects
Lead sponsor
Omeros Corporation
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2004
Completion date
March 31, 2011
Enrollment
480 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament reconstruction